EyeGate Pharmaceuticals Garners $11,000,000 New Funding Round

  • Feed Type
  • Date
    12/21/2009
  • Company Name
    EyeGate Pharmaceuticals
  • Mailing Address
    100 Beaver Street Waltham, MA 02453
  • Company Description
    EyeGate Pharma is focused on replacing ocular injections and other invasive methods of ocular disease treatment. Our goal is to build a pipeline of safer, more effective and patient friendly ocular treatments based on our EyeGate® II Delivery System.
  • Website
    http://www.eyegatepharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.